Coagulopathy after cardiac surgery with cardiopulmonary bypass is a serious complication that may result in massive bleeding requiring transfusion of significant amounts of blood products, plasma, and platelets. In addition to increased patient morbidity and mortality it is associated with longer hospital stay and increased resource utilization. The current review discusses aspects in cardiopulmonary bypass-induced coagulopathy with emphasis on point-of-care testing and individualized “goal-directed” therapy in patients who develop excessive bleeding after cardiac surgery.
You may also like
The Effects of Alpha-Stat and pH-Stat Blood Gas Management Utilizing Inadequate Flows during Cardiopulmonary Bypass (Video)
Rachel Saniuk discuses the effects of Alpha and pH-Stat blood gas management combined with inadequate flows during CPB (14 minutes).
Activated Coagulation Time Versus Intrinsically Activated Modified Rotational Thromboelastometry in Assessment of Hemostatic Disturbances and Blood Loss after Protamine Administration in Elective Cardiac Surgery
The study aim was to compare the accuracy of hemostatic disorder detection between two point-of-care devices.
First Transportation on a Berlin Heart EXCOR Left Ventricular Assist Device as a Bridge to Transplantation to Arkansas Children’s Hospital (EP Video)
Dorothy Garbin discusses the first transportation on a Berlin Heart EXCOR Left Ventricular Assist Device (7:52 minutes).